Skip Navigation
Menu
ACP Journal Club |19 January 2009

Review: Inhaled anticholinergics increase risk for major cardiovascular events in chronic obstructive pulmonary disease

Matthew B. Stanbrook, MD, PhD

Article, Author, and Disclosure Information
FULL TEXT
Singh S, Loke YK, Furberg CD. Inhaled anticholinergics and risk of major adverse cardiovascular events in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis. JAMA. 2008;300:1439-50. 18812535

Cardiology:

Pulmonology:

See alsoTiotropium reduced exacerbations but not rate of FEV1 decline in patients with COPD using other respiratory medications
The review by Singh and colleagues and the trial by Tashkin and colleagues were done to address uncertainty about the risks and benefits of inhaled anticholinergic therapy in COPD. However, understanding the discrepant findings is a challenge. Why did the meta-analysis show a 52% increase in myocardial infarction...
FULL TEXT
PDF
Not Available
Citations
Citation

Stanbrook MB. Review: Inhaled anticholinergics increase risk for major cardiovascular events in chronic obstructive pulmonary disease. Ann Intern Med. 2009;150:JC1–6. doi: https://doi.org/10.7326/0003-4819-150-2-200901200-02006

Download citation file:

© 2019

×
Permissions

Published: Ann Intern Med. 2009;150(2):JC1-6.

DOI: 10.7326/0003-4819-150-2-200901200-02006

0 Citations

Related Articles
In COPD, new use of long-acting bronchodilators was linked to CV events at ≤ 30 days, but not > 30 days
Annals of Internal Medicine; 168 (8): JC47
Comparison of Inhaled Long-Acting β-Agonist and Anticholinergic Effectiveness in Older Patients With Chronic Obstructive Pulmonary Disease: A Cohort Study
Annals of Internal Medicine; 154 (9): 583-592
Review: Tiotropium does not increase risk for cardiovascular events in chronic obstructive pulmonary disease
Annals of Internal Medicine; 153 (2): JC1-2
Recent use of ipratropium bromide increased risk for cardiovascular events in chronic obstructive pulmonary disease
Annals of Internal Medicine; 153 (2): JC1-3
View MoreView Less

Journal Club
In COPD, new use of long-acting bronchodilators was linked to CV events at ≤ 30 days, but not > 30 days
Annals of Internal Medicine; 168 (8): JC47
Review: Tiotropium does not increase risk for cardiovascular events in chronic obstructive pulmonary disease
Annals of Internal Medicine; 153 (2): JC1-2
Recent use of ipratropium bromide increased risk for cardiovascular events in chronic obstructive pulmonary disease
Annals of Internal Medicine; 153 (2): JC1-3
Review: In hypertension, intensive BP goals reduce CV events; self vs office BP measures do not improve BP at 12 mo
Annals of Internal Medicine; 169 (6): JC26
View MoreView Less

Related Point of Care
Chronic Obstructive Pulmonary Disease
Annals of Internal Medicine; 154 (7): ITC4-1
Chronic Obstructive Pulmonary Disease
Annals of Internal Medicine; 148 (5): ITC3-1
View MoreView Less

Related Topics
Chronic Obstructive Airway Disease
Pulmonary/Critical Care

Chronic Obstructive Airway Disease, Pulmonary/Critical Care.

PubMed Articles
Impact of pre-existing hypertension and control status before atrial fibrillation onset on cardiovascular prognosis in patients with non-valvular atrial fibrillation: A real-world database analysis in Japan.
J Clin Hypertens (Greenwich) 2019.
Association of Long-term Ambient Ozone Exposure With Respiratory Morbidity in Smokers.
JAMA Intern Med 2019.
View More

Results provided by: PubMed

CONTINUE WITH LIMITED ACCESS
Annals of Internal Medicine
To receive access to the full text of freely available articles, alerts, and more. You will be directed to acponline.org to complete your registration.
×
acp link acp
silverchair link silverchair

Copyright © 2019 American College of Physicians. All Rights Reserved.

Print ISSN: 0003-4819 | Online ISSN: 1539-3704

Privacy Policy

|

Conditions of Use

This site uses cookies. By continuing to use our website, you are agreeing to our privacy policy. | Accept
×

You need a subscription to this content to use this feature.

×
PDF Downloads Require Access to the Full Article.
Annals of Internal Medicine
To receive access to the full text of freely available articles, alerts, and more. You will be directed to acponline.org to complete your registration.
×
Access to this Free Content Requires Users to be Registered and Logged In. Please Choose One of the Following Options
Annals of Internal Medicine
To receive access to the full text of freely available articles, alerts, and more. You will be directed to acponline.org to complete your registration.
×